ASICS, an acronym for Anima Sana In Corpore Sano—a sound mind in a sound body—has long been a titan in the running shoe industry. The Japanese brand has cultivated a reputation for meticulous craftsmanship, biomechanical innovation, and a commitment to serving runners of all levels. However, navigating the extensive ASICS lineup can be a daunting task, with a plethora of models like the Nimbus, Kayano, Novablast, and Metaspeed all vying for attention. Understanding the distinct purpose of each category is the key to unlocking the perfect shoe for your specific running needs.

The Cushioning Classics: The Pillars of Daily Training

For decades, ASICS has built its legacy on providing premium cushioning for daily training. The GEL-NIMBUS and GEL-CUMULUS series represent the gold standard for neutral runners who prioritize comfort and protection over everything else. The GEL-NIMBUS is the flagship of this category, a shoe known for its “luxurious” ride and maximum shock absorption. It’s designed for runners who want to feel pampered on long runs, with the latest iterations featuring the brand’s softest foams. As one expert described it, the Nimbus is for those “who seek maximum cushioning,” regardless of their weight . Its sibling, the GEL-CUMULUS, is often described as the “safety and structure” option, offering a slightly lower profile while sharing similar midsole foams, making it a reliable and responsive daily trainer for high-mileage road running .

The Stability Heritage: Support for the Overpronator

While the Nimbus focuses on plushness, its counterpart, the GEL-KAYANO, reigns supreme in the stability category. The KAYANO, celebrating over 30 years of innovation, is built for runners whose feet roll inward excessively (overpronate) . Its key technology, the 4D GUIDANCE SYSTEM™, is a holistic approach to stability. Instead of simply adding a dense post on the medial side, this system uses a combination of midsole geometry, a lateral decoupling groove, and specific foam placements to help guide the foot back to a neutral position more efficiently . It provides “holistic, adaptive stability,” allowing overpronators to enjoy high levels of cushioning without sacrificing support . The GT-2000 serves as a more affordable and slightly lighter option for runners needing support, utilizing the more subtle 3D GUIDANCE SYSTEM™, proving that stability doesn’t have to break the bank .

The ‘BLAST’ Family: A New Era of Bounce

The modern ASICS lineup has been revolutionized by the arrival of the BLAST family, a series of shoes that prioritize energy return and a “fun” running experience. The NOVABLAST is the genesis of this movement, acting as the starting point for runners seeking “everyday bounce” . It introduced a bouncy, soft midsole that was “unlike anything ASICS had offered before,” and has since become a wildly popular daily trainer that is as comfortable on easy recovery runs as it is on tempo efforts . As runners progress, the family branches out. The SUPERBLAST is the long-run specialist, offering a max-cushion experience in a deceptively lightweight package. The latest SUPERBLAST 3, for example, is 10 grams lighter and 15.4% bouncier than its predecessor, providing a “do-it-all shoe” DNA for accumulating high mileage .

For those seeking speed without the rigidity of a full carbon plate, ASICS offers the SONICBLAST and MEGABLAST. The SONICBLAST incorporates a Pebax® plate sandwiched between two layers of foam, making it the “uptempo bounce” shoe ideal for threshold workouts and as a bridge to the world of plated racing . The MEGABLAST, on the other hand, is the “ultimate bounce,” featuring a single layer of ASICS’s most resilient foam, FF TURBO². It offers an energetic, pogo-stick-like sensation for those looking for a “unique experience,” .

The Apex of Speed: The METASPEED Series and Beyond

At the very top of the ASICS hierarchy are the METASPEED racing shoes. These are the brand’s super shoes, built with a full-length carbon plate and premium foams for racing on marathon day. Unlike a one-size-fits-all approach, the Metaspeed series is split into two distinct models based on running form: the METASPEED SKY for runners who increase their stride length as they speed up, and the METASPEED EDGE for those who increase their cadence . This nuanced approach, designed at the ASICS Institute of Sport Science, demonstrates how deeply the brand analyzes biomechanics. The MAGIC SPEED acts as a more accessible “gateway” to the carbon-plated world, offering a less aggressive ride and higher durability for speed training, making it a perfect companion for competitive runners .

The breadth of the ASICS running shoe lineup is a testament to its dedication to runners of all types. Whether you are a neutral runner seeking the “warm hug” of the Gel-Cumulus, an overpronator requiring the adaptive stability of the Gel-Kayano, or a speedster looking for the pogo-stick bounce of the Megablast, ASICS has meticulously engineered a shoe for you. The key is to understand your own biomechanics—your gait, your training paces, and your mileage—and match them to the shoe designed for that specific purpose. In the world of ASICS, there is a science to every step, and a shoe to support it.

Knee osteoarthritis (OA) represents a significant global health challenge, affecting over 365 million people worldwide and serving as a primary driver of healthcare costs and disability . For decades, the standard care pathway has followed a predictable trajectory: patient education and exercise, pain medication, corticosteroid injections, and ultimately, joint replacement surgery. Yet this traditional model leaves many patients in a “gray area”—individuals whose symptoms are not adequately managed by conservative approaches but who are not yet candidates for, or are unwilling to undergo, surgical intervention . APOS therapy, a novel biomechanical foot-worn device, has emerged as a compelling solution for this underserved population, offering a non-invasive, mechanism-driven approach that addresses the root causes of pain rather than merely masking symptoms.

Understanding the Mechanism: Beyond Simple Unloading

APOS (All Phase Of Stance) therapy operates on a sophisticated dual mechanism that distinguishes it from conventional orthotics or footwear. The system comprises a specialized shoe with two convex rubber pods, called “Pertupods,” affixed to the sole. These pods are individually calibrated by trained clinicians based on gait analysis, with their position, size, and convexity customized to address each patient’s unique biomechanical dysfunction .

The first mechanism provides immediate biomechanical unloading. By precisely shifting the location of the Pertupods, the device alters the foot’s center of pressure, redirecting ground reaction forces away from the painful joint compartment. This can reduce the knee’s varus (adduction) moment by approximately 17%, directly decreasing the mechanical stress on the arthritic area . This effect is substantially greater than that observed with traditional lateral wedge orthotics, which typically achieve only 5-6% reduction and have shown inconsistent clinical efficacy.

However, the more transformative aspect of APOS lies in its second mechanism: neuromuscular retraining. The convex design of the pods introduces controlled micro-instability during walking, narrowing the base of support and challenging the patient’s postural stability . This intentional perturbation forces the lower extremity muscles to fire differently, activating and strengthening the neuromuscular pathways responsible for stability and control. Over time, this “built-in exercise intervention” retrains the patient’s gait pattern, teaching the body to move in a more biomechanically efficient and less painful manner . Critically, this retraining effect persists even when the device is not being worn, offering the potential for long-term functional improvement beyond the immediate pain relief .

Clinical Evidence and Guideline Endorsement

The clinical efficacy of APOS therapy is supported by a growing body of evidence, including a landmark randomized controlled trial published in the Journal of the American Medical Association (JAMA) . This robust research has demonstrated significant and clinically meaningful outcomes. A 70% average reduction in knee pain has been reported, with 89% of patients eligible for total knee replacement avoiding surgery for up to six years . Furthermore, treatment has been associated with a 61% decrease in pain medication use and a substantial 85% reduction in opioid usage, highlighting its potential to combat the ongoing opioid crisis .

These clinical outcomes translate into tangible healthcare system benefits. A retrospective claims analysis of over 600 patients demonstrated that APOS treatment was associated with an 80% reduction in healthcare costs compared to standard care, attributed to lower rates of surgeries, fewer specialist visits, and reduced need for imaging and injections . Patients with knee pain reported significant pain decreases of 39% and 35% at three and six months post-treatment, respectively . This real-world evidence of both clinical effectiveness and cost-savings is a powerful driver for adoption .

The strength of the evidence has led to recognition in major clinical guidelines. The European Alliance of Associations for Rheumatology (EULAR) updated its recommendations to include APOS for the management of knee and hip osteoarthritis . Similarly, the UK’s National Institute for Health and Care Excellence (NICE) has issued guidance supporting the technology, validating its adoption for a clearly defined patient cohort . NICE endorsement is particularly critical for NHS adoption, providing the assurance required for commissioners and providers to integrate the technology into routine care pathways .

Positioning in the Care Pathway

APOS therapy is not intended to replace all conservative measures but rather to serve as a highly effective option for patients who have failed standard non-surgical treatments. The NICE guidance specifies its intended use for adults with knee OA who have not responded adequately to standard care . Professor Oliver Pearce, a consultant orthopedic surgeon, describes this as the “gray area”—patients for whom core treatments like exercise, weight loss, physiotherapy, and steroid injections have provided insufficient relief .

The practical implementation of APOS involves a structured, year-long program. Following an initial gait analysis and device calibration, patients are prescribed a home-based regimen, typically wearing the device for 30 to 60 minutes per day during daily activities . Regular follow-ups allow for recalibration as the patient’s gait improves, ensuring the therapy remains optimally effective. This home-based nature is a key advantage, empowering patients to actively participate in their rehabilitation while maintaining their normal routines.

APOS therapy represents a paradigm shift in knee osteoarthritis management, moving beyond symptomatic relief to address the underlying biomechanical drivers of pain and dysfunction. By combining targeted load redistribution with neuromuscular retraining, it offers a non-invasive, evidence-based solution that can dramatically reduce pain, improve function, and delay or eliminate the need for surgery. With robust clinical evidence, inclusion in major guidelines, and demonstrable cost-effectiveness, APOS is poised to become an integral part of the modern knee OA care pathway, offering new hope for the millions of patients currently trapped in the “gray area” between conservative care and joint replacement .

Anterior compartment syndrome, particularly its chronic exertional form (CECS), represents a frustrating and often debilitating condition for runners. Characterized by a progressive increase in intracompartmental pressure during exercise, it leads to pain, tightness, numbness, and in severe cases, foot drop that forces the runner to stop. The classic presentation involves symptoms that predictably arise after a specific distance or duration of running and resolve with rest. For years, the standard of care has been a binary choice: conservative management or surgical fasciotomy. However, a significant paradigm shift is occurring, driven by a growing body of evidence that champions a more sophisticated, biomechanical approach to treatment, with running gait retraining emerging as a powerful and potentially curative conservative intervention.

Understanding the Challenge: Pathophysiology and Diagnosis

Chronic exertional compartment syndrome most commonly affects the anterior compartment of the lower leg, a closed fascial space that houses the tibialis anterior muscle and other essential structures. During running, the demand for blood flow increases, causing muscles to swell. In patients with CECS, this swelling leads to a pathological rise in pressure within the compartment, compromising circulation, nerve function, and muscle performance. This condition is surprisingly prevalent, affecting approximately 30% of runners.

The diagnostic process begins with a thorough clinical examination. A classic history—pain and tightness in the anterolateral leg that appears predictably after 10-15 minutes of running and resolves within 15 minutes of stopping—is highly suggestive. Physical findings may be unremarkable at rest, but examination immediately after running can reveal tightness, decreased sensation in the first dorsal web space, and weakness in ankle dorsiflexion and toe extension. Definitive diagnosis is achieved through intracompartmental pressure testing, where a needle catheter measures pressures before and after exercise. Pressures exceeding 15 mm Hg at rest or 30 mm Hg one minute post-exercise are generally considered diagnostic.

The Traditional Paradigm: Conservative Care and Fasciotomy

Historically, treatment has been divided into non-operative and surgical options. Initial conservative management typically includes a combination of rest, ice, stretching, and strengthening exercises. The goal is to reduce muscle tightness, improve conditioning, and manage symptoms. For many, however, this approach provides only temporary or partial relief, leading to the recommendation for surgery.

Open fasciotomy, the traditional surgical procedure, involves making an incision through the fascia to create more room for muscle expansion and relieve pressure. It is an invasive procedure, often requiring several weeks of recovery before a return to high-impact activity, and its success rates can vary significantly between different populations. While civilian return-to-sport rates can be high (up to 96% in one study), results in military personnel are less consistent. The invasiveness and variable outcomes of fasciotomy, alongside the recognition that surgery does not address the underlying mechanics that may have caused the condition, have spurred a search for more effective non-surgical options.

A New Frontier: Gait Retraining as Primary Treatment

The most exciting development in the treatment of anterior compartment syndrome is the move toward addressing the root biomechanical cause. This approach is founded on the simple yet powerful idea that the repetitive overload of the anterior compartment is a direct result of specific running mechanics, particularly overstriding and a rearfoot strike pattern.

A heel-strike running gait, where the foot lands well in front of the body’s center of mass, places a significant and repetitive eccentric load on the tibialis anterior muscle. This overactivity is believed to be the primary driver of the pathological pressure increase. Gait retraining aims to fundamentally change this pattern by transitioning a runner from a rearfoot to a forefoot or midfoot strike. This shift redistributes the workload to the larger, more fatigue-resistant calf muscles (gastrocnemius and soleus) and significantly reduces the demand on the anterior compartment.

The evidence supporting this approach is compelling and growing. Several case series and studies have demonstrated remarkable outcomes. In a 2011 study, two subjects with confirmed CECS underwent a six-week forefoot running intervention. Not only did their post-running intracompartmental pressures decrease, but they were also able to run pain-free distances of up to 12.87 km and 6.44 km at a 7-month follow-up. This success was later replicated in a larger cohort of ten patients who were indicated for surgical release. After six weeks of forefoot strike training, their post-run compartment pressures dropped from an average of 78.4 mm Hg to 38.4 mm Hg. Their pain and disability scores improved dramatically, and importantly, no patient required surgery. Another case report documented a 34-year-old female athlete with a 20-year history of CECS who was able to avoid surgery after a six-week gait retraining program. Her post-run anterior compartment pressure decreased from 67 mm Hg to 45 mm Hg, and she became completely asymptomatic while running.

The Elements of Gait Retraining

A successful gait retraining program is multi-faceted. Key components include:

1. Foot Strike Pattern Transition: The primary objective is to shift from a rearfoot to a midfoot or forefoot strike pattern. This can be achieved through various coaching cues, such as “run more quietly” or focusing on a light, quick footfall.
2. Cadence Increase: Runners are often instructed to increase their step rate (cadence) to approximately 170-180 steps per minute. A higher cadence naturally reduces step length and decreases the braking forces at foot strike, which in turn lessens the dorsiflexion angle and activation of the tibialis anterior.
3. Shorter Strides and Reduced Overstriding: Cues are given to ensure the foot lands closer to the body’s center of mass. This reduces overstriding, a primary contributor to the anterior compartment overload.
4. Footwear Modification: The transition can be facilitated by using footwear with a lower “heel-to-toe drop,” which encourages a more natural forefoot or midfoot strike pattern.

A typical program progresses over six weeks, starting with short, manageable distances, often on a treadmill for consistency, and often incorporating drills like barefoot running to encourage a more natural gait. The use of a metronome to help the runner maintain a target cadence is a common and effective tool.

A Paradigm of Movement as Medicine

The treatment of anterior compartment syndrome in runners is evolving away from a reactive model of symptom suppression and surgery toward a proactive model of biomechanical correction. While traditional conservative measures like rest and stretching have their place, and fasciotomy remains a viable option for refractory cases, the emergence of gait retraining as a primary intervention represents a paradigm shift. By directly addressing the mechanical overload of the anterior compartment through modifications in running form, clinicians can offer patients a non-invasive, sustainable, and highly effective path to recovery. The evidence suggests that this approach does more than just alleviate symptoms; it fundamentally alters the biomechanical demands of running, often eliminating the root cause of the condition and allowing runners to return to their sport stronger and more resilient than before.

Ankylosing spondylitis (AS) is a chronic, inflammatory, and autoimmune disease most commonly associated with pain, stiffness, and eventual fusion of the spine . However, this systemic condition casts a much wider net, profoundly impacting peripheral joints and entheses—the sites where tendons and ligaments attach to bone. The feet, being the foundational pillars of the human body, are a frequent and often underappreciated battleground in this disease. The impact of AS on the feet extends far beyond mere discomfort, encompassing a range of painful conditions like enthesitis and arthritis, leading to significant functional impairment, deformity, and a measurable decline in quality of life .

The Primacy of Enthesitis: A Battle at the Heel

The hallmark of foot involvement in AS is enthesitis, a painful inflammation at the insertion points of tendons and ligaments. This is not merely a symptom but a core pathological feature of spondyloarthritis . In the foot, the primary targets are the Achilles tendon, where it attaches to the calcaneus (heel bone), and the plantar fascia, which connects the heel to the toes. This inflammation manifests clinically as Achilles tendinitis and plantar fasciitis, conditions that can cause debilitating heel pain with every step .

The prevalence of these issues is remarkably high. Research indicates that radiological enthesopathies of the Achilles tendon and plantar fascia are present in a significant majority of patients, with one study finding calcaneal spurs and Achilles enthesopathy in 57.4% of individuals with axial spondyloarthritis . This is not simply a clinical finding; it is a direct contributor to the pain and functional limitations that characterize the disease. Further underscoring the frequency of foot problems, a case-control study found significant differences between AS patients and healthy controls across all domains of foot health, including foot pain, function, and overall foot health, as measured by the Foot Health Status Questionnaire (FHSQ) .

Beyond Enthesitis: A Spectrum of Pathology

While enthesitis is central, the impact of AS on the foot is a complex tapestry of related pathologies. Synovitis, the inflammation of the lining of the joints, can affect the ankles and other joints of the foot, causing swelling, warmth, and pain . In severe cases, this can contribute to joint deformities. A study using magnetic resonance imaging (MRI) revealed the true extent of subclinical disease, finding that while only 13% of patients had clinical signs of foot involvement, a striking 91% displayed abnormalities on MRI scans .

This imaging study highlighted a wide array of issues, including bone erosions (65%), Achilles tendinitis (61%), joint effusion (43%), and plantar fasciitis (40%) . It further demonstrated that the hindfoot was the most commonly affected anatomical region (83%), followed by the midfoot (69%) and ankle (22%) . These findings are crucial as they reveal that foot damage can be occurring silently, without overt symptoms, potentially leading to long-term structural damage if left unaddressed. For instance, rare complications, such as “tamale foot”—a pseudotumor caused by mucopolysaccharide deposits in the extensor tendon sheaths—or even neuropathic arthropathy linked to cauda equina syndrome, illustrate the potential for serious, albeit uncommon, foot manifestations .

Functional, Personal, and Social Impact

The consequences of these pathological changes are not confined to the foot itself; they radiate outward to affect every aspect of a person’s life. The feet are our primary interface with the world, and their dysfunction directly impacts mobility. The study by Cortes-Rodríguez et al. found that AS patients scored significantly lower in domains of physical activity and social capacity, directly linking foot pain to a reduced ability to engage in everyday activities and social interactions . This can lead to a cascade of challenges: difficulty standing for long periods, changes in gait that can cause secondary pain in the knees and hips, and the emotional toll of chronic pain and reduced independence . As one patient poignantly noted, “Feet are literally your foundation, so if they’re messed up, you’re messed up” .

The Importance of Multidisciplinary Care

Given the profound impact of AS on foot health, a proactive, multidisciplinary approach to management is essential. This is not an issue to be managed by a rheumatologist alone. The British Society for Rheumatology guideline recommends that healthcare professionals should routinely ask patients about foot symptoms and, when appropriate, conduct a clinical examination that includes gait assessment, footwear evaluation, and an assessment of the neurovascular status of the foot .

Specialized podiatry care is a cornerstone of this approach. Podiatrists can provide a range of interventions, from prescribing custom orthotics to improve foot mechanics and offload painful areas, to offering advice on appropriate footwear, and performing steroid injections to manage acute inflammation . They can also address structural issues like deformities and help manage skin and nail pathologies that can become more serious in patients with compromised mobility . This collaborative care model is vital for mitigating the progression of foot problems and preserving the quality of life for those living with AS.

The effects of ankylosing spondylitis on the feet are pervasive, complex, and deeply impactful. It is more than just “foot pain”; it is a manifestation of the systemic inflammation at the heart of the disease, affecting entheses, joints, and bones, often silently. The resulting functional limitations can significantly diminish a patient’s quality of life, affecting their ability to work, socialize, and maintain independence. Recognizing the centrality of foot health in AS is not just a clinical necessity but a profound act of empathy for patients whose foundation is literally crumbling beneath them.

The Achilles tendon, the strongest tendon in the human body, is paradoxically one of the most frequently ruptured, with incidence rates rising to approximately 31 cases per 100,000 people as recreational sports participation increases . This injury, which typically affects active individuals between 30 and 50 years of age, represents a significant challenge for both patients and clinicians . The treatment of an Achilles tendon rupture has evolved considerably, moving beyond a simple dichotomy of surgery versus casting toward a more nuanced approach that integrates shared decision-making, advances in surgical technique, and early functional rehabilitation to optimize recovery and return to activity.

The Initial Decision: Navigating the Surgical Divide

The foundational decision in managing an acute Achilles rupture is whether to pursue operative or non-operative treatment. This choice is not about identifying a single superior method but rather about selecting the most appropriate path based on a patient’s individual risk profile and goals. The primary trade-off is well-established in the literature: surgical repair offers a significantly lower risk of re-rupture, while conservative management avoids the serious complications inherent to surgery, such as infection and nerve injury .

The evidence clearly demonstrates this balance of risks and benefits. A large meta-analysis of over 35,000 patients found that surgical treatment reduced the relative risk of re-rupture by 56% compared to non-operative care. However, this benefit came at a cost: surgery was associated with a significantly higher rate of wound infections and nerve injuries . The numbers help contextualize this trade-off. For every 100 patients treated, surgery prevents approximately 3.5 re-ruptures but causes roughly 3.3 more nerve injuries and 0.5 more infections compared to conservative treatment . Critically, when functional outcomes and patient satisfaction are measured over the long term using validated instruments like the Achilles Tendon Total Rupture Score (ATRS), there is often no statistically significant difference between the groups . This suggests that for many, the lower risk of re-rupture from surgery may be offset by its higher risk of other complications, making patient preference a central factor in the decision.

From Open Repair to Emerging Techniques

For patients who choose surgery—often younger, more active individuals or high-level athletes—the type of surgical procedure is the next consideration. Open repair, where the surgeon makes a single large incision to directly suture the tendon ends, has long been the gold standard . Its primary advantage is the strength of the repair, which allows for early mobilization and weight-bearing. However, it carries the highest risk of wound-healing problems.

To mitigate these risks, minimally invasive and percutaneous techniques have been developed. While these approaches aim to reduce wound complications by using smaller incisions, current evidence suggests that complication rates may be similar to open surgery, and the debate regarding their overall efficacy continues . Emerging technologies, such as the use of suture anchors to fix the tendon to the heel bone, represent the next frontier, though long-term clinical data are still forthcoming . The optimal technique remains a point of controversy, and the decision often depends on surgeon expertise and the specific characteristics of the tear .

The Critical Role of Rehabilitation

Regardless of the chosen treatment path, successful recovery from an Achilles rupture hinges on a structured and progressive rehabilitation protocol. The historical approach of prolonged, rigid immobilization has been replaced by a philosophy of early functional rehabilitation . This shift is based on the principle that controlled mechanical loading encourages collagen alignment, strengthens the healing tendon, and reduces muscle atrophy .

The rehabilitation process is typically divided into phases. The immediate post-injury or post-operative phase (weeks 0-2) focuses on protecting the repair or the natural healing process. Patients are placed in a walking boot with heel wedges to keep the foot in a plantarflexed (toes pointed down) position, which reduces tension on the tendon . This initial period is critical for wound healing and minimizing the risk of early complications . A subsequent phase (weeks 2-8) involves a slow, graduated removal of the heel wedges, bringing the foot to a neutral (flat) position while allowing progressive weight-bearing as tolerated .

Advanced rehabilitation, often beginning around six to eight weeks post-injury, is where the real work begins. Exercises transition from seated heel raises and ankle movements to standing double-leg and, eventually, single-leg heel raises . A key caution in this phase is to avoid over-stretching the tendon, particularly by not pulling the toes back toward the shin too aggressively, as the healing tendon is still vulnerable and can elongate or re-rupture . The final phase is a return to sport, a lengthy process that involves plyometrics, jumping, and sport-specific drills. This progression is often criterion-based, meaning patients advance based on achieving specific strength and functional milestones, such as having at least 90% of the calf strength of their uninjured leg, rather than simply by time . This entire process is lengthy; while daily activities like walking may resume in three months, a full return to high-level sports can take between six to twelve months or even longer . The use of ultrasound imaging to guide rehabilitation is an emerging strategy that may help individualize this process and potentially accelerate recovery by objectively assessing tendon healing .

The treatment of an Achilles tendon rupture has transitioned from a one-size-fits-all approach to a personalized strategy that balances the competing risks of re-rupture and surgical complications. The decision between operative and non-operative management is a shared one, guided by the patient’s age, activity level, and values. Surgical repair minimizes re-rupture risk for high-demand individuals, while conservative management offers a path free from surgical complications. What unites these approaches is the growing recognition that early functional rehabilitation, rather than prolonged immobilization, is the cornerstone of a successful outcome. The long recovery requires patience and a structured program to restore strength and function, ultimately enabling a safe return to the activities that define an active life.

An accessory navicular is an extra bone found on the inner side of the foot, just above the arch. Present in approximately 4% to 21% of the population, this congenital anomaly is often an incidental finding that causes no issues. However, for a small percentage—less than 1%—this extra bone becomes painful, leading to a condition known as accessory navicular syndrome (ANS). This pain typically arises in adolescence when the bone fully ossifies, or following an injury that disrupts the cartilaginous connection between the extra bone and the main navicular bone. The primary driver of pain is often inflammation at the attachment site of the posterior tibial tendon, a crucial structure that supports the foot’s arch.

The approach to treating an accessory navicular is a stepwise journey. It begins with simple, non-invasive measures, progresses to more structured conservative care, and, in a minority of cases where symptoms persist, culminates in surgical intervention. The vast majority of patients find relief without needing an operation.

Step 1: First-Line Conservative Management

For the vast majority of patients, the first line of defense against accessory navicular pain is conservative management. The primary goal at this stage is to reduce inflammation and offload the painful area. The foundational approach is often summarized by the RICE protocol: Rest, Ice, Compression, and Elevation. This is particularly effective for acute flare-ups or symptoms triggered by a specific activity. Modifying or ceasing activities that exacerbate the pain is a critical first step.

Beyond initial symptom management, treatment focuses on reducing friction and mechanical stress. The bony bump on the inside of the foot can be irritated by tight or poorly fitting shoes, so switching to wider, more supportive footwear is a simple but effective change. Over-the-counter arch supports or custom-made orthotics can also be beneficial. These inserts support the foot’s arch, reducing the workload on the posterior tibial tendon and, consequently, the friction and movement at the painful accessory navicular site. For many, this simple change can provide significant relief.

Step 2: Advanced Non-Surgical Interventions

If initial shoe changes and rest are insufficient, a more aggressive conservative approach is warranted. The cornerstone of this phase is immobilization. Placing the foot in a short leg walking boot or cast for 4 to 6 weeks provides complete rest to the area, allowing the acute inflammation to subside. Studies show that immobilization, often in conjunction with orthotics, can be effective, with one pediatric study finding that 40% of patients treated with immobilization alone achieved pain relief.

Physical therapy plays a pivotal role in this stage. A supervised, customized strengthening and stretching program is crucial for a full recovery, particularly for active individuals and athletes. Key components include calf stretching and exercises to strengthen the ankle and foot stabilizers, which help support the arch and reduce stress on the posterior tibial tendon. A structured rehabilitation program, as demonstrated in a case study of a young boxer, can be instrumental in facilitating a safe and timely return to high-level competition without the need for surgery.

For symptom management, nonsteroidal anti-inflammatory drugs (NSAIDs) can be used to reduce both pain and swelling. If pain is severe and unresponsive to oral medications, a healthcare provider might consider a cortisone injection. However, this is typically approached with caution, as injections can have undesirable side effects, including weakening the posterior tibial tendon.

The success of this entire non-operative phase often takes time. One study highlighted that patients who achieved complete pain relief did so after an average of 8 months of conservative treatment, and many require an average of over two trials of different therapies. Overall, conservative management can be highly effective. Research indicates that while only about 28% of patients experience complete pain relief with non-operative care, the majority can avoid surgery, with some studies showing that up to 70% of patients will not require an operation.

Step 3: Surgical Options for Refractory Cases

When symptoms persist after a thorough course of conservative management—typically 6 to 12 months—surgery becomes a viable option. The primary indications for surgery are persistent pain, recurrent inflammation of the posterior tibial tendon, and significant interference with daily life or athletic performance.

Several surgical techniques exist, each with its own nuances. The two most common are simple excision and the Kidner procedure.

1. Simple Excision: This procedure involves the straightforward removal of the extra bone. It is often considered for smaller accessory naviculars that are not associated with significant flatfoot deformity.
2. Kidner Procedure: This is the most frequently performed surgery, considered a gold standard for treating all subtypes of symptomatic accessory navicular. It involves not only the removal of the accessory bone but also the reattachment of the posterior tibial tendon to the main navicular bone, which addresses the underlying mechanical dysfunction that often causes pain.

A systematic review found that both procedures lead to satisfactory improvements in pain and function. Postoperative outcomes for the Kidner procedure are often rated as excellent, with one review finding a 58% excellent rate. It’s important to note that the Kidner procedure can involve a more complex recovery.

The Surgical Journey and Recovery

Surgery for an accessory navicular is typically performed as an outpatient procedure, and the patient is placed in a non-weight-bearing cast for about 6 to 8 weeks. The recovery timeline is gradual:

• 0-8 Weeks: Non-weight-bearing in a cast.
• 8 Weeks: Transition to partial weight-bearing with crutches and a rigid-soled shoe.
• 10 Weeks: Can begin full weight-bearing and gentle return to normal activities.
• 4 Months: Swelling is still noticeable, especially after activity.
• 6 Months: The healing process continues, with swelling and discomfort diminishing.
• 12 Months: Complete healing is expected.

While surgery is effective, it is not without risks. Potential complications include infection, delayed wound healing, nerve injury, and DVT. A significant consideration is that about 20% of patients can still experience arch pain following surgery, a condition that might require further conservative care. The overall complication rate is considered moderate, with one systematic review finding an 11% complication rate for the Kidner procedure.

A Glimpse into the Future: Novel Treatments

Emerging research offers a potential future option. Transarterial microembolization (TAME) is a minimally invasive technique that targets the inflammatory neovessels responsible for chronic pain. A recent study on 75 patients with refractory ANS showed a significant and durable reduction in pain, with the average pain score dropping from 6.9 to 1.4 out of 10 at the final follow-up, with no major complications. While promising, TAME is an emerging technique and not yet a standard of care.

The treatment of an accessory navicular is a testament to the principle of “start low and go slow.” The journey begins with simple, non-invasive interventions like rest, shoe modifications, and orthotics. For those who need more, a structured program of immobilization and supervised physical therapy often provides significant relief. Only when these measures fail after many months is surgery considered, with the Kidner procedure being the most established and effective option. Understanding this hierarchy empowers patients to work with their physicians to navigate their treatment path effectively, with the goal of returning to a pain-free, active life.

In the pantheon of sporting legends, few images are as enduring as that of Abebe Bikila, the barefoot Ethiopian, gliding through the torchlit streets of Rome to win the Olympic marathon. His victory at the 1960 Games was not merely a sporting achievement; it was a seismic event that reshaped the landscape of long-distance running and announced the arrival of African athletes on the world stage. Bikila became an icon of the barefoot runners because his choice to run without shoes was not a gimmick, but a powerful symbol of national pride, natural athleticism, and the unyielding spirit of a new Africa .

A Humble Beginning and an Unexpected Debut

Born on the same day as the 1932 Olympic marathon, in the rural Ethiopian village of Jato, Bikila’s path to glory was improbable . He was a shepherd’s son who walked over 80 miles to Addis Ababa to join the Imperial Bodyguard . His athletic talent was spotted by a Swedish-born coach, Onni Niskanen, who began to refine his raw ability .

Bikila was a last-minute addition to the Ethiopian Olympic team, replacing Wami Biratu, who had broken his ankle . Arriving in Rome as a complete unknown, he faced an additional hurdle. The team’s shoe sponsor, Adidas, did not have a pair that fit him comfortably, and wearing ill-fitting shoes would have been disastrous. In the hours before the race, Bikila made the decision that would define his legacy: he would run barefoot, just as he had trained in the highlands of Ethiopia .

The Triumph in Rome and the Symbol of a New Africa

The 1960 Olympic marathon was a unique spectacle, held in the late afternoon and finishing in the dark, with Italian soldiers lighting the course with torches . The race became a duel between Bikila and the Moroccan runner, Rhadi Ben Abdesselem. The pair ran side-by-side for most of the race .

It was the location of Bikila’s decisive move that added a layer of profound symbolism to his victory. He made his final break at the Piazza di Porta Capena, the site of the Obelisk of Axum. This ancient monument had been looted by Italian troops from Ethiopia during their invasion in 1936 . For Bikila, a member of the Imperial Guard, outpacing his rival at the foot of this plundered relic was a powerful act of retribution. It was a moment where a son of a shepherd, on Italian soil, reclaimed a symbol of his nation’s pride . As he famously said, “I wanted the world to know that my country, Ethiopia, has always won with determination and heroism” . His world record time of 2:15:16.2 was the first Olympic gold medal for a black African, and it served as a beacon of hope and possibility during a period of decolonization . Haile Gebrselassie, himself an Ethiopian running legend, later noted, “We [African runners] are the result of Abebe Bikila” .

Beyond the Bare Feet: An Enduring Legacy

While his barefoot victory in Rome made him an icon, Bikila cemented his status as a legend at the 1964 Tokyo Olympics. Despite having undergone an appendectomy just 40 days before the race, he won again, this time wearing shoes and setting another world record . He was the first man to successfully defend an Olympic marathon title .

Bikila’s barefoot running became a symbol of a pure, natural form of athleticism that was unburdened by modern equipment. It stood in stark contrast to the highly commercialized nature of sport and presented the image of an athlete who was one with the ground . His tragic life, which ended in a car accident that left him paralyzed, only added to the profound nature of his story . The Abebe Bikila Award, given to individuals for their contribution to long-distance running, ensures that his name continues to inspire .

Abebe Bikila’s iconic status is built on more than his victories. He became the “barefoot runner” because the simplicity of his choice resonated with a world witnessing the rise of a new Africa . His triumph was a defiant statement of identity and resilience. By running on the ancient cobblestones of Rome without shoes, he created an image of pure, unadorned courage that continues to inspire generations of runners from East Africa and beyond, proving that determination and heroism can conquer any obstacle.

Author: Craig Payne

The human gait cycle is a complex interplay of biomechanical forces, a symphony of motion that efficiently propels the body forward. While the casual observer may see only a simple act of walking, the trained eye of a clinician or biomechanist perceives a detailed narrative of joint angles, muscle activations, and ground reaction forces. Among the many subtle events that occur during a single step, the abductory twist—a brief, rapid, and often visually imperceptible medial rotation of the foot just before and at the moment of heel-off—stands out as a critical and highly significant event. Its presence, magnitude, and timing offer a profound window into the functional integrity of the lower limb, serving as a vital sign of normal mechanics and a key indicator of underlying pathology.

To understand the abductory twist’s significance, one must first appreciate its role within the normal gait cycle. During the stance phase, the foot transitions from a flexible shock absorber at initial contact to a rigid lever for propulsion at terminal stance. This transformation is driven by the subtalar joint, which pronates (everts) to unlock the midfoot upon loading, and then supinates (inverts) to create a stiff beam for push-off. The abductory twist occurs precisely at this critical transition point, as the body’s center of mass passes over the weight-bearing foot. As the heel begins to rise, the tibia externally rotates, and in a normally functioning kinetic chain, the foot must internally rotate to maintain a stable, weight-bearing position beneath the body. This relative medial rotation of the foot is the abductory twist. Its magnitude is typically small, ranging from 5 to 10 degrees, and its presence is a testament to the foot’s ability to accommodate transverse plane rotations originating from the pelvis and hip. A smooth, controlled abductory twist is a hallmark of an efficient and healthy gait, indicating that the foot is both supple enough to adapt to the ground and stable enough to generate forward thrust.

The true clinical significance of the abductory twist, however, lies in its pathological variations. An abnormal twist—one that is absent, excessive, or mistimed—is a powerful diagnostic sign that can reveal dysfunction anywhere along the kinetic chain. The most classic example is its role in forefoot pathology. Hallux rigidus, a degenerative condition of the first metatarsophalangeal (MTP) joint, severely restricts dorsiflexion. To compensate, the foot is forced to rely on the more mobile lateral column for push-off. This compensation manifests as an exaggerated and prolonged abductory twist. The foot rotates excessively internally to unlock the midfoot, allowing the lateral structures to bear more load and effectively “roll around” the stiff great toe. A clinician observing this pronounced twist on a gait analysis knows to suspect a limitation in first MTP joint motion, even before a physical exam is performed. Conversely, an absent abductory twist is equally telling. It often signifies a rigid, hyper-supinated foot, where the subtalar joint is locked and unable to adapt to the external rotation of the tibia. This lack of motion, often seen in patients with high-arched, cavus feet, forces the rotation to occur at more proximal joints like the knee, placing the patient at a significantly higher risk for lateral ankle sprains and iliotibial band syndrome.

The abductory twist is not merely a local foot event; it is the critical link between the foot and the rest of the body’s movement. The kinetic chain theory posits that motion at one joint affects motion at all others. The external rotation of the tibia during terminal stance is a direct result of pelvic rotation and hip extension. The foot’s ability to accommodate this rotation through the abductory twist is what protects the knee and hip from excessive torsional stresses. When this accommodation is compromised, the chain of compensation inevitably travels upward. An excessive abductory twist, for example, necessitates an accompanying internal rotation of the tibia. This abnormal tibial rotation places undue strain on the medial structures of the knee, contributing to conditions such as patellofemoral pain syndrome or even accelerating the progression of medial compartment knee osteoarthritis. In this way, the abductory twist serves as a mechanical fuse. Its presence or absence is a direct indicator of whether the foot is successfully absorbing and dissipating rotational forces, thereby protecting the more proximal joints. For the clinician performing a gait analysis, observing the twist is not just about the foot; it is about predicting the health of the entire lower quarter and spine.

Finally, the practical applications of understanding the abductory twist are immense in clinical practice. For podiatrists and orthotists, it is a key metric for footwear and orthotic prescription. An excessive twist may indicate a need for a medial heel skive or a wedged orthotic to help control pronation. For the physical therapist, observing a patient’s twist pattern provides objective feedback on the effectiveness of rehabilitation exercises aimed at improving hip strength or core stability. It transforms a subjective observation into a measurable outcome. In the world of sports, analyzing the abductory twist can help identify athletes at risk of injury, allowing for preventative interventions. If a runner shows a sudden increase in their twist magnitude, it could signal an upcoming bout of plantar fasciitis, shin splints, or a stress fracture.

The abductory twist is a deceptively simple motion that carries immense biomechanical significance. It is a faithful translator, converting the rotational demands of the upper body into the ground-based reality of the foot. Its presence signifies a healthy, adaptable, and efficient lower limb. Its absence or exaggeration is a red flag, pointing to dysfunction in the foot itself or compensatory strategies for problems arising elsewhere. For the discerning clinician, the abductory twist is far more than a fleeting rotational movement; it is a vital diagnostic clue, a predictor of injury, and a critical guide for effective treatment, underscoring the profound interconnectedness of the human musculoskeletal system.

Author: Craig Payne

Chilblains are a condition characterized by reddish, itching, and swollen area on the skin as a result of cold vulnerability. The most beneficial treatment solution is to utilize a effective ointment and make use of socks that keep the foot warm. When considering picking the best socks for chilblains, it’s extremely important to put in priority warmth, insulation, rather than get socks that impair the circulation. There are several concerns to think about, including materials, size, and insulation. A number of the most useful sock alternatives that may help include:

Wool socks: Wool is really a natural insulator which will offer warmth and control temperature effectively. Cashmere wool is a lot more warming in comparison with merino wool, especially for socks for the cold feet.

Thermal socks: Thermal socks are made to provide additional warmth in cold conditions. Look for socks with a high TOG (Thermal Overall Grade) score to ensure that ideal insulating material.

Moisture-wicking socks: It’s important to keep the feet dry to protect yourself from chilblains. Seek out socks with moisture-wicking properties that may pull perspiration away from your skin which helps regulate dampness amounts.

Compression socks: Compression socks can increase blood flow, that is very important to preventing and managing chilblains. They might boost blood circulation and reduce puffiness. Look for hosiery having graduated compression to get the best results. Compression hosiery really should not be used if you have poor blood circulation because they will further reduce that.

Layering socks: Layering socks can offer extra insulation which help manage temperature. Consider wearing a thin moisture-wicking sock as a first layer to maintain your feet dry, followed by a heavier wool or thermal sock for warmth.

Fleece-lined socks: Fleece-lined socks have a soft coating that gives extra insulation along with comfort. They could help trap warmth and keep your feet cozy in cold weather.

Take into account, it is probably extremely important to keep the entire body warm and protected when dealing with chilblains. Aside from wearing appropriate socks, you need to dress in layers, put on insulated shoes, and avoid long term exposure to cold temperatures. If you are having continual or acute signs and symptoms, it’s best to check with a podiatrist for further guidance and therapy.

Author: Craig Payne

How your skin on the feet responds and reacts to a particular cream is very variable between individuals, so it is hard to advise one that might be the best for you. What foot cream or lotion which works well for one individual will not work well for the next individual. It is important that those with dry skin do apply a cream or lotion to moisturize the skin as there can be issues such as cracks or fissures in the skin that may develop. These cracks may bleed or become infected. For this reason those with dry skin do need to take it serious and to apply a cream to hydrate their dried out skin.

As it is hard to advise one particular cream or lotion as the response is to variable, it is often a great idea to start with the urea based creams or lotions as the science has shown that there is a lack of urea in the epidermis in almost everyone who has the dryer skin conditions. It would be logical to start with these urea based creams to see how the skin on your feet does respond to them before trying some other types of creams if it does not help. This will involve a bit of trail and error on the users part to get it right and find the cream or lotion that best suits the skin on your feet.

The urea creams and lotions have two different effects, depending on the concentration of urea in the cream. Less than about 20% (ie 15%) the cream is more helpful to help the skin retain moisture. Above about 20% (ie 25%) the urea cream is more helpful at getting rid of the dryer looser or flaky skin. As with any dry skin cream or lotion, it has to be used. There is no point in getting any good cream (or even a cheap bad one!) but it will not do a lot of you did not apply it. The cream or lotion should be used several times a day and at least daily after that once the skin has got better.

Author: Craig Payne